Services

Toxicology

Pharmacology

Animal Model Development

Medical Device Testing

In Vitro Screening

Custom Assay Development

Vivarium Rental

Histology

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Species

Non-human Primates

Dogs

Minipigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Careers

Request a Quote

☰

Nabriva's Stock Explodes as Pneumonia Drug Wows in Two Phase III Trials

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x430-stock-positive.jpg" NAME"Nabriva's Stock Explodes as Pneumonia Drug Wows in Two Phase III Trials" ALT"Nabriva's Stock Explodes as Pneumonia Drug Wows in Two Phase III Trials"September 18, 2017By Alex Keown,…

Continue ReadingNabriva's Stock Explodes as Pneumonia Drug Wows in Two Phase III Trials

Harvard Biotech Guru, VCs Launch With $55 Million Series A

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks5.jpg" NAME"Harvard Biotech Guru, VCs Launch LifeMine Therapeutics With $55 Million Series A" ALT"Harvard Biotech Guru, VCs Launch LifeMine Therapeutics With $55 Million Series A"September 18, 2017By Mark Terry,…

Continue ReadingHarvard Biotech Guru, VCs Launch With $55 Million Series A

Amgen, Allergan Make History With First Cancer Biosimilar OK&mdash;Will Take on Genentech's $6 Billion Best-Seller

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-fda.jpg" NAME"Amgen, Allergan Make History With First Cancer Biosimilar OKWill Take on Genentech's $6 Billion Best-Seller" ALT"Amgen, Allergan Make History With First Cancer Biosimilar OKWill Take on Genentech's $6…

Continue ReadingAmgen, Allergan Make History With First Cancer Biosimilar OK&mdash;Will Take on Genentech's $6 Billion Best-Seller

Catabasis To Present Results From The Open-Label Extension Of The Movedmd Phase II Trial Of Edasalonexent In Duchenne Muscular Dystrophy In A Late Breaking Session Of The World Muscle Society

  • Post author:
  • Post category:BioPharma

  Life Sciences Jobs   ... Source: BioSpace

Continue ReadingCatabasis To Present Results From The Open-Label Extension Of The Movedmd Phase II Trial Of Edasalonexent In Duchenne Muscular Dystrophy In A Late Breaking Session Of The World Muscle Society

Massachusetts' Flexion Terminates R&D Deal With AstraZeneca PLC

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks2.jpg" NAME"Massachusetts' Flexion Terminates R&D Deal With AstraZeneca PLC" ALT"Massachusetts' Flexion Terminates R&D Deal With AstraZeneca PLC"September 15, 2017By Alex Keown, BioSpace.com Breaking News Staff<BR... Source: BioSpace

Continue ReadingMassachusetts' Flexion Terminates R&D Deal With AstraZeneca PLC

Show Me The Money: Bay Area???s Top 5 Venture Capital-Backed Biotechs

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-investor.jpg" NAME"Show Me The Money: Bay Areas Top 5 Venture Capital-Backed Biotechs" ALT"Show Me The Money: Bay Areas Top 5 Venture Capital-Backed Biotechs"September 15, 2017By Mark Terry, BioSpace.com Breaking…

Continue ReadingShow Me The Money: Bay Area???s Top 5 Venture Capital-Backed Biotechs